Skip to content
PMCBPharmaCyte Biotech, Inc.

PMCB holders

Who holds PharmaCyte Biotech, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
27
Shares held
681.2K
Value held
$279.6K
Opened
4
Closed
9

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Citadel Advisors LLC140.4K−50.5%$57.7K0%Nov 16, 2026
Geode Capital Management, LLC123.9K−0.3%$50.9K0%Nov 6, 2026
Renaissance Technologies LLC64.7K+70.4%$26.6K0%Nov 12, 2026
Jane Street Group, LLC64.2K+113.4%$26.3K0%Nov 12, 2026
Vanguard Capital Management LLC56.8K±0%$23.3K0%Nov 13, 2026
Northern Trust Corp32.6K±0%$13.4K0%Nov 16, 2026
XTX Topco Ltd30.4K−11.1%$12.5K0.1%Nov 16, 2026
Susquehanna International Group, LLP30.1K−33.0%$12.3K0%Nov 16, 2026
StoneX Group Inc.30KNew$12.3K0.1%Nov 3, 2026
Schonfeld Strategic Advisors LLC26.2K−2.5%$10.8K0%Nov 16, 2026
Vanguard Fiduciary Trust Co23.5K±0%$9.6K0%Nov 13, 2026
Equitec Proprietary Markets, LLC22.2K±0%$9.1K0.1%Nov 4, 2026
Ground Swell Capital, LLC19.6KNew$8.1K0.1%Nov 9, 2026
Commonwealth Equity Services, LLC10.3K−49.4%$4.2K0%Nov 2, 2026
Tower Research Capital LLC (TRC)4.9K−0.3%$2K0%Nov 16, 2026
Allworth Financial LP714New$2940%Nov 17, 2026
Osaic Holdings, Inc.303±0%$1260%Nov 12, 2026
Keating Financial Advisory Services, Inc.134New$550%Nov 12, 2026
UBS Group AG30−99.3%$120%Nov 10, 2026
BFSG, LLC5±0%$30%Oct 30, 2026
Barclays PLC4−97.9%$20%Nov 6, 2026
CoreCap Advisors, LLC4±0%$20%Oct 8, 2026
Caldwell Sutter Capital, Inc.2±0%$10%Nov 9, 2026
Financial Consulate, Inc2±0%$10%Oct 23, 2026
NewEdge Advisors, LLC2±0%$10%Nov 13, 2026
BlackRock, Inc.1±0%$00%Nov 13, 2026
Covestor Ltd275±0%$00%Oct 30, 2026